Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors

AbstractPurpose of ReviewThe epidemiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) is continuously evolving with an increasing life span and the prevalence of metabolic diseases, including obesity, diabetes, cardiovascular disease, and hypertension. As a result, there is a substantial financial strain on health care.Recent FindingsRecent studies and clinical trials have strengthened the relationship of known risk factors of BPH and LUTS. These include metabolic syndrome, diabetes, obesity, hypertension, and elevated serum dihydrotestosterone. Excessive consumption of red meat, saturated fat, bread, poultry, and starch was positively associated with symptomatic LUTS. Efforts to enhance treatment adherence, a healthy diet, and moderate physical exercise were noted as factors that can improve the treatment and management of BPH and LUTS.SummaryBPH is a prevalent condition among aging men. As it becomes a clinical entity through the development of LUTS, it significantly reduces the quality of life of those affected through sub-optimal bladder storage, voiding difficulties, and sexual dysfunctions. Many of the risk factors for BPH and LUTS can be reduced through moderate to intense physical exercise and consumption of dietary ß-carotene, polyunsaturated fatty acids, linoleic acid, zinc, and vitamin A and C.
Source: Current Bladder Dysfunction Reports - Category: Urology & Nephrology Source Type: research

Related Links:

Authors: Miura M, Fujinami N, Shimizu Y, Mizuno S, Saito K, Suzuki T, Konishi M, Takahashi S, Gotohda N, Suto K, Yoshida T, Nakatsura T Abstract Predicting the risk of hepatocellular carcinoma (HCC) recurrence before treatment is necessary for developing subsequent treatment policies. Several tumor markers found in blood, such as alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II), are presently used to determine the occurrence and recurrence of HCC and to predict patient prognosis. However, these markers are insufficient for these purposes as certain patients have HCC recur...
Source: Oncology Letters - Category: Cancer & Oncology Tags: Oncol Lett Source Type: research
PMID: 32213150 [PubMed - in process]
Source: Current Pharmaceutical Design - Category: Drugs & Pharmacology Authors: Tags: Curr Pharm Des Source Type: research
Publication date: Available online 29 March 2020Source: Meat ScienceAuthor(s): Vladana Grabe┼ż, Bjørg Egelandsdal, Nils Petter Kjos, Ingrid Marie Håkenåsen, Liv Torunn Mydland, Jon Olav Vik, Elin Hallenstvedt, Hanne Devle, Margareth Øverland
Source: Meat Science - Category: Food Science Source Type: research
Publication date: Available online 29 March 2020Source: Food HydrocolloidsAuthor(s): Hualu Zhou, Yunbing Tan, Shanshan Lv, Jinning Liu, Jorge L. Muriel Mundo, Long Bai, Orlando J. Rojas, David Julian McClements
Source: Food Hydrocolloids - Category: Food Science Source Type: research
Authors: Kawada T PMID: 32216510 [PubMed - as supplied by publisher]
Source: Renal Failure - Category: Urology & Nephrology Tags: Ren Fail Source Type: research
Authors: Kim SY, Jeon SW, Lim WJ, Oh KS, Shin DW, Cho SJ, Park JH, Shin YC Abstract OBJECTIVE: The aim of study is to investigate the relationship between serum vitamin D, c-reactive protein (CRP) levels, and anxiety symptoms. METHODS: Serum vitamin D and CRP levels of 51,003 Korean adult participants were collected retrospectively. Anxiety symptoms were assessed using the Korean version of Beck Anxiety Inventory. Logistic regression was used to estimate the odds ratio (ORs) of anxiety symptoms by serum vitamin D and CRP levels. The regression was adjusted for covariates, and each model was adjusted mutually fo...
Source: Psychiatry Investigation - Category: Psychiatry Tags: Psychiatry Investig Source Type: research
Authors: Shibayama Y, Wada N, Baba S, Obara S, Sakai H, Usubuchi H, Terae S, Nakamura A, Atsumi T Abstract Patients with primary aldosteronism (PA) are complicated by metabolic syndrome more frequently than those without PA. Hyperaldosteronism has been reported to be associated with a higher prevalence of non-alcoholic fatty liver disease (NAFLD). We aimed to clarify the risk factors for hepatic steatosis in the two subtypes of PA, comparing the status of hepatic steatosis in each of these subtypes. This was a retrospective observational study. We enrolled patients with an aldosterone producing adenoma (APA) (n = 3...
Source: Endocrine Journal - Category: Endocrinology Tags: Endocr J Source Type: research
This study aimed to compare the characteristics of patients with AIs with those of patients with adrenal tumors detected during HT screening. We retrospectively analyzed patients referred to our division for detailed examination of adrenal tumors between April 2009 and April 2017. When the purposes of imaging tests included HT screening, we defined adrenal tumors as HT associated, otherwise as strictly defined AIs. We reviewed data on age, sex, purpose and modality of imaging, location of tumor, tumor diameter, and hormonal evaluation. We identified 104 patients with HT-associated adrenal tumors and 413 with AIs. Patients ...
Source: Endocrine Journal - Category: Endocrinology Tags: Endocr J Source Type: research
Authors: Sen B, Sharma P, Blackburn J, Morrisey M, Corvey K, Menachemi N, Caldwell C, Becker D Abstract Background: The increase in pediatric obesity rates is well documented. The extent of corresponding increases in diagnoses of obesity-related conditions (Ob-Cs) and associated medical costs for children in public insurance programs is unknown. Methods: Retrospective claims data linked to enrollees' demographic data for Alabama's Children's Health Insurance Program (ALL Kids) 1999-2015 were used. Multivariate linear probability models were used to estimate the likelihood of having any Ob-C diagnoses. Two-part mode...
Source: Childhood Obesity - Category: Eating Disorders & Weight Management Tags: Child Obes Source Type: research
Conclusions: These studies demonstrate the ability of intact ZnO NP to induce membrane permeability and cytotoxicity without the contribution of dissolved Zn2+, suggesting that ZnO NP toxicity does not necessarily depend upon Zn2+. The stability of ZnO NP inside the phagolysosomes suggests that LMP is the result of the toxic effect of intact ZnO NP on phagolysosomal membranes. PMID: 32216500 [PubMed - as supplied by publisher]
Source: Inhalation Toxicology - Category: Respiratory Medicine Tags: Inhal Toxicol Source Type: research
More News: Benign Prostatic Hyperplasia | Cardiology | Cardiovascular | Clinical Trials | Diabetes | Diets | Eating Disorders & Weight Management | Endocrinology | Epidemiology | Health Management | Heart | Hypertension | Meat | Metabolic Syndrome | Nutrition | Obesity | Omega 6 | Saturated Fat | Sports Medicine | Study | Urology & Nephrology | Vitamin A | Vitamins | Zinc